We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

82 hedge funds and large institutions have $179M invested in VanEck Biotech ETF in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $911K

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

4% more funds holding

Funds holding: 79 → 82 (+3)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

8.02% less ownership

Funds ownership: 34.65% → 26.63% (-8%)

28% less capital invested

Capital invested by funds: $249M → $179M (-$69.4M)

Holders
82
Holders Change
+3
Holders Change %
+3.8%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
24
Closed
11
Calls
$1.48M
Puts
$911K
Net Calls
+$572K
Net Calls Change
-$2.84M

Top Buyers

Rank Fund Capital Flow
1
CG
Colony Group
Massachusetts
+$5.02M
2
TC
Trust Company
Kansas
+$4.39M
3
WI
WBI Investments
New Jersey
+$2.67M
4
OLA
Oliver Luxxe Assets
New Jersey
+$1.61M
5
ECM
Endurant Capital Management
California
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$51.7M
2
UBS Group
UBS Group
Switzerland
-$13.7M
3
Creative Planning
Creative Planning
Kansas
-$2.42M
4
AL
Aspiriant LLC
California
-$2.13M
5
PAG
Private Advisor Group
New Jersey
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$1.32M +$1.07M +8,349 +374%
TRCT
27
Tower Research Capital (TRC)
New York
$1.24M +$1.24M +9,709 +3,822%
Ameriprise
28
Ameriprise
Minnesota
$947K -$38.6K -302 -4%
TBA
29
Train Babcock Advisors
New York
$902K +$924K +7,237 New
Wells Fargo
30
Wells Fargo
California
$887K +$275K +2,151 +43%
ClearBridge Investments
31
ClearBridge Investments
New York
$872K – – –
Janney Montgomery Scott
32
Janney Montgomery Scott
Pennsylvania
$794K -$109K -850 -12%
GJIC
33
Gamble Jones Investment Counsel
California
$748K – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$722K -$128 -1 -0%
IA
35
IFP Advisors
Florida
$678K -$24.8K -194 -3%
WJA
36
Williams Jones & Associates
New York
$674K -$8.94K -70 -1%
Capital Fund Management (CFM)
37
Capital Fund Management (CFM)
France
$673K +$690K +5,400 New
SBH
38
Segall Bryant & Hamill
Illinois
$561K +$25.5K +200 +5%
BPC
39
Banque Pictet & Cie
Switzerland
$467K – – –
IAMOG
40
Investors Asset Management of Georgia
Georgia
$461K – – –
CAN
41
Cetera Advisor Networks
California
$460K -$79.2K -620 -14%
SC
42
Scotia Capital
Ontario, Canada
$450K +$160K +1,250 +53%
OAM
43
Occidental Asset Management
California
$445K +$456K +3,572 New
VWA
44
V Wealth Advisors
Kansas
$427K -$6.38K -50 -1%
First Manhattan
45
First Manhattan
New York
$373K – – –
AB
46
Atlas Brown
Kentucky
$361K +$6K +47 +2%
TCM
47
Tufton Capital Management
Maryland
$330K – – –
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$324K -$1.4M -10,960 -81%
SWP
49
Stratos Wealth Partners
Ohio
$271K -$3.45K -27 -1%
B
50
Bailard
California
$269K – – –
1
2
3 4

BBH Hedge Fund Activity: Q4 2017 in Review

82 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2017, worth a combined $179M — down 28% from $249M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BBH positions and 11 closed out — a net gain of 3 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was Colony Group, opening a new position worth an estimated $5.02M. The largest seller was AllianceBernstein, cutting an estimated $51.7M.

  • 82 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2017, up from 79 in Q3 2017.
  • Funds reported $179M of VanEck Biotech ETF stock for Q4 2017, down 28% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q4 2017 and 11 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2017 was Colony Group, an estimated $5.02M added.
  • The largest VanEck Biotech ETF seller in Q4 2017 was AllianceBernstein, an estimated $51.7M sold.

Based on aggregated 13F filings for Q4 2017.